Keylika
Frederik Ceyssens has had a diverse work experience. Frederik is the founder and CEO of ReVision Implant NV, a position they have held since August 2020. Additionally, they are currently serving as the CTO of Keylika since July 2022. Before their entrepreneurial roles, they worked as an FWO postdoctoral research fellow at Kuleuven from September 2010 to August 2020.
Frederik Ceyssens pursued their education at KU Leuven from 1998 to 2003. During this period, they obtained a degree in Microelectronics, earning the title of Ir.
This person is not in any teams
This person is not in any offices
Keylika
Keylika developed a platform synthesis technology for mixed ligand metal complexes that is used to generate a multitude of organometallic drugs for treating a wide range of therapeutic conditions: hematology, pain and inflammation, metabolic disorders to infectious diseases and oncology.